Private equity has had a long involvement with and continues to stay active in the business of health care.
In a panel discussion at the University of Pennsylvania’s Leonard Davis Institute of Health Economics, Rachel M. Werner, MD, PhD, executive director at the institute, said the number of private equity deals in health care has increased from 325 in 2010 to more than 1,000 in 2021, reports Ocular Surgery News.
The driving force behind these deals, according to Sabrina T. Howell, PhD, associate professor of finance at New York University Stern School of Business, is the concentration of money in the health care sector.
“In 2021, U.S. health expenditures were 18% of GDP,” she said. “At the same time, the private equity industry has grown dramatically over the past couple of decades.” Read more.
